These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 17374431)
21. Neonatal outcome in polycystic ovarian syndrome patients treated with metformin during pregnancy. Kovo M; Weissman A; Gur D; Levran D; Rotmensch S; Glezerman M J Matern Fetal Neonatal Med; 2006 Jul; 19(7):415-9. PubMed ID: 16923696 [TBL] [Abstract][Full Text] [Related]
22. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet. Glueck CJ; Goldenberg N; Sieve L; Wang P Metabolism; 2008 Jul; 57(7):954-60. PubMed ID: 18555837 [TBL] [Abstract][Full Text] [Related]
23. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Tan BK; Heutling D; Chen J; Farhatullah S; Adya R; Keay SD; Kennedy CR; Lehnert H; Randeva HS Diabetes; 2008 Jun; 57(6):1501-7. PubMed ID: 18375437 [TBL] [Abstract][Full Text] [Related]
24. Thyroidal effect of metformin treatment in patients with polycystic ovary syndrome. Rotondi M; Cappelli C; Magri F; Botta R; Dionisio R; Iacobello C; De Cata P; Nappi RE; Castellano M; Chiovato L Clin Endocrinol (Oxf); 2011 Sep; 75(3):378-81. PubMed ID: 21521311 [TBL] [Abstract][Full Text] [Related]
25. Soluble platelet/endothelial cell adhesion molecule (sPECAM)-1 is increased in polycystic ovary syndrome and related to endothelial dysfunction. Pepene CE Gynecol Endocrinol; 2012 May; 28(5):370-4. PubMed ID: 22456311 [TBL] [Abstract][Full Text] [Related]
26. Dietary intervention versus metformin to improve the reproductive outcome in women with polycystic ovary syndrome. A prospective comparative study. Qublan HS; Yannakoula EK; Al-Qudah MA; El-Uri FI Saudi Med J; 2007 Nov; 28(11):1694-9. PubMed ID: 17965792 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial. Trolle B; Flyvbjerg A; Kesmodel U; Lauszus FF Hum Reprod; 2007 Nov; 22(11):2967-73. PubMed ID: 17766923 [TBL] [Abstract][Full Text] [Related]
28. Impact of metformin therapy in patients with polycystic ovarian syndrome. Hasan JA; Memon GU J Coll Physicians Surg Pak; 2005 Nov; 15(11):712-5. PubMed ID: 16300709 [TBL] [Abstract][Full Text] [Related]
29. Plasma cytokines in obese women with polycystic ovary syndrome, before and after metformin treatment. Jakubowska J; Bohdanowicz-Pawlak A; Milewicz A; Szymczak J; Bednarek-Tupikowska G; Demissie M Gynecol Endocrinol; 2008 Jul; 24(7):378-84. PubMed ID: 18645710 [TBL] [Abstract][Full Text] [Related]
30. Effects of metformin treatment in women with polycystic ovary syndrome depends on insulin resistance. Nawrocka J; Starczewski A Gynecol Endocrinol; 2007 Apr; 23(4):231-7. PubMed ID: 17505944 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of metformin supplementation during ovarian stimulation of lean PCOS patients undergoing in vitro fertilization. Kumbak B; Kahraman S Acta Obstet Gynecol Scand; 2009; 88(5):563-8. PubMed ID: 19306135 [TBL] [Abstract][Full Text] [Related]
33. Hyperreninemia characterizing women with polycystic ovary syndrome improves after metformin therapy. Diamanti-Kandarakis E; Economou FN; Livadas S; Tantalaki E; Piperi C; Papavassiliou AG; Panidis D Kidney Blood Press Res; 2009; 32(1):24-31. PubMed ID: 19212122 [TBL] [Abstract][Full Text] [Related]
34. Effect of the insulin sensitizers metformin and pioglitazone on endothelial function in young women with polycystic ovary syndrome: a prospective randomized study. Naka KK; Kalantaridou SN; Kravariti M; Bechlioulis A; Kazakos N; Calis KA; Makrigiannakis A; Katsouras CS; Chrousos GP; Tsatsoulis A; Michalis LK Fertil Steril; 2011 Jan; 95(1):203-9. PubMed ID: 20684955 [TBL] [Abstract][Full Text] [Related]
35. Use of metformin in polycystic ovary syndrome. Mathur R; Alexander CJ; Yano J; Trivax B; Azziz R Am J Obstet Gynecol; 2008 Dec; 199(6):596-609. PubMed ID: 19084097 [TBL] [Abstract][Full Text] [Related]
36. Metformin and glitazones: do they really help PCOS patients? Pillai A; Bang H; Green C J Fam Pract; 2007 Jun; 56(6):444-53. PubMed ID: 17543254 [TBL] [Abstract][Full Text] [Related]
37. Estradiol-to-testosterone ratio is associated with response to metformin treatment in women with clomiphene citrate-resistant polycystic ovary syndrome (PCOS). Horng SG; Wang TH; Wang HS Chang Gung Med J; 2008; 31(5):477-83. PubMed ID: 19097595 [TBL] [Abstract][Full Text] [Related]
38. Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin. Luque-Ramírez M; Alvarez-Blasco F; Uriol Rivera MG; Escobar-Morreale HF Hum Reprod; 2008 Jul; 23(7):1594-601. PubMed ID: 18375410 [TBL] [Abstract][Full Text] [Related]
39. Enoxaparin-metformin and enoxaparin alone may safely reduce pregnancy loss. Ramidi G; Khan N; Glueck CJ; Wang P; Goldenberg N Transl Res; 2009 Jan; 153(1):33-43. PubMed ID: 19100956 [TBL] [Abstract][Full Text] [Related]
40. Effect of Metformin on Microvascular Endothelial Function in Polycystic Ovary Syndrome. Heidari B; Lerman A; Lalia AZ; Lerman LO; Chang AY Mayo Clin Proc; 2019 Dec; 94(12):2455-2466. PubMed ID: 31806099 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]